Patient basic information Patient: Ms. Anastasia Clark) Nationality: Tajikistan Disease diagnosis: Liver cancer Diagnostic hospital: HQ0 treatment program: Blood stem cell transplant + chemotherapy Holidays: 85 days Treatment cost: about 1079136 yuan Treatment effect: partial relief The patient is from Tajikistan and was diagnosed with liver cancer locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process.
The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 85 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results: Patient's final part of relief.
At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track the recovery through a remote follow-up system. 'Mrs. Anastasia has been criticized by experts as a typical case of cross-border suspected seriousness clinical cases.
M4A relies on a multidisciplinary collaborative mechanism to develop a blood stem cell transplant + chemotherapy program for liver cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated. (Image taken from M5A official news report and medical scenarios)